Literature DB >> 3173432

Tumors of the brain and nervous system after radiotherapy in childhood.

E Ron1, B Modan, J D Boice, E Alfandary, M Stovall, A Chetrit, L Katz.   

Abstract

We investigated the relation between radiotherapy in childhood for tinea capitis and the later development of tumors of the brain and nervous system among 10,834 patients treated between 1948 and 1960 in Israel. Benign and malignant tumors were identified from the pathology records of all Israeli hospitals and from Israeli national cancer and death registries. Doses of radiation to the neural tissue were retrospectively estimated for each patient (mean, 1.5 Gy). Sixty neural tumors developed in the patients exposed as children, and the 30-year cumulative risk (+/- SE) was 0.8 +/- 0.2 percent. The incidence of tumors was 1.8 per 10,000 persons per year. The estimated relative risk as compared with that for 10,834 matched general-population controls and 5392 siblings who had not been irradiated was 6.9 (95 percent confidence interval, 4.1 to 11.6) for all tumors and 8.4 (confidence interval, 4.8 to 14.8) when the analysis was restricted to neural tumors of the head and neck. Increased risks were apparent for meningiomas (relative risk, 9.5; n = 19), gliomas (relative risk, 2.6; n = 7), nerve-sheath tumors (relative risk, 18.8; n = 25), and other neural tumors (relative risk, 3.4; n = 9). A strong dose--response relation was found, with the relative risk approaching 20 after estimated doses of approximately 2.5 Gy. Our study confirms that radiation doses on the order of 1 to 2 Gy can significantly increase the risk of neural tumors.

Entities:  

Mesh:

Year:  1988        PMID: 3173432     DOI: 10.1056/NEJM198810203191601

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  173 in total

1.  Update of the Texaco mortality study 1947-93: Part II. Analyses of specific causes of death for white men employed in refining, research, and petrochemicals.

Authors:  B J Divine; C M Hartman; J K Wendt
Journal:  Occup Environ Med       Date:  1999-03       Impact factor: 4.402

2.  Low incidence of brain tumors among Ethiopian immigrants in Israel.

Authors:  Lee Yaari; Ora Paltiel; Micha Barchana; Irena Liphshiz; Yigal Shoshan
Journal:  J Neurooncol       Date:  2010-06-08       Impact factor: 4.130

3.  International incidence of central nervous system tumors in children.

Authors:  G Filippini; A Artuso
Journal:  Ital J Neurol Sci       Date:  1992-06

Review 4.  Update on meningiomas.

Authors:  Santosh Saraf; Bridget J McCarthy; J Lee Villano
Journal:  Oncologist       Date:  2011-10-25

Review 5.  Fractionated radiotherapy for intracranial meningiomas.

Authors:  Vinai Gondi; Wolfgang A Tome; Minesh P Mehta
Journal:  J Neurooncol       Date:  2010-09-01       Impact factor: 4.130

Review 6.  Cancer risk related to gastrointestinal diagnostic radiation exposure.

Authors:  Mimi L Chang; Jason K Hou
Journal:  Curr Gastroenterol Rep       Date:  2011-10

7.  Population-based risks of CNS tumors in survivors of childhood cancer: the British Childhood Cancer Survivor Study.

Authors:  Aliki J Taylor; Mark P Little; David L Winter; Elaine Sugden; David W Ellison; Charles A Stiller; Marilyn Stovall; Clare Frobisher; Emma R Lancashire; Raoul C Reulen; Michael M Hawkins
Journal:  J Clin Oncol       Date:  2010-11-15       Impact factor: 44.544

Review 8.  Assessment of the risk for developing a second malignancy from scattered and secondary radiation in radiation therapy.

Authors:  Harald Paganetti
Journal:  Health Phys       Date:  2012-11       Impact factor: 1.316

Review 9.  Current knowledge on tumour induction by computed tomography should be carefully used.

Authors:  Cristian Candela-Juan; Alegría Montoro; Enrique Ruiz-Martínez; Juan Ignacio Villaescusa; Luis Martí-Bonmatí
Journal:  Eur Radiol       Date:  2013-11-27       Impact factor: 5.315

10.  Three polymorphisms of DNA repair gene XRCC1 and the risk of glioma: a case-control study in northwest China.

Authors:  Gaofeng Xu; Maode Wang; Wanfu Xie; Xiaobin Bai
Journal:  Tumour Biol       Date:  2013-09-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.